---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007304"
form_type: "8-K"
ticker: "CUE"
cik: "0001645460"
company_name: "Cue Biopharma, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:32:23.551099+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Howson to retire from Cue Biopharma board at 2023 annual meeting

## Summary
- Ms. Howson informed the board on March 7, 2023 of her retirement.
- She will not stand for re-election at the 2023 annual meeting.
- Retirement is not due to any disagreement with company operations.
- Howson currently serves on Compensation and Governance committees.
- No replacement director has been announced.

## SEC filing metadata
- accession: 0000950170-23-007304
- form_type: 8-K
- ticker: CUE
- cik: 0001645460
- company_name: Cue Biopharma, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645460/000095017023007304/0000950170-23-007304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645460/000095017023007304/cue-20230307.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007304
- JSON: https://secwatch.observer/filing/0000950170-23-007304.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007304.txt

## Key facts
- Executive change
  Ms. Howson departed as Director at Cue Biopharma, Inc..
  - Action: retire
  - Role: Director
  source text: On March 7, 2023, Ms. Howson informed the Board of Directors of Cue Biopharma, Inc. (the “Company”) of her intent to retire from the Board of Directors and not stand for re-election at the Company’s 2023 annual meeting of stockholders (the “2023 Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645460/000095017023007304/0000950170-23-007304-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.